• HNF4A-AS1 Loss Drives Sorafenib Resistance in HCC

  2026-09-01

  The 2024 Theranostics study identifies liver-enriched lncRNA HNF4A-AS1 as a regulator of sorafenib-induced ferroptosis in hepatocellular carcinoma. Its loss increases DECR1 expression, depletes intracellular polyunsaturated fatty acids, and supports drug resistance through an METTL3–m6A–YTHDF3 regulatory axis.

• CFTRinh-172 as a Functional Lens on CFTR Trafficking

  2026-08-31

  CFTRinh-172 is a selective CFTR inhibitor for separating channel function from plasma-membrane abundance. This article connects trafficking biology, epithelial assay design, and secretory diarrhea models through a function-first experimental framework.

• EPZ5676: A Precise DOT1L Inhibitor Workflow

  2026-08-31

  EPZ5676 enables selective DOT1L inhibition, linking biochemical target engagement with H3K79 methylation inhibition and MLL-rearranged leukemia models. This workflow-focused guide covers assay setup, exposure design, controls, troubleshooting, and practical interpretation for reproducible epigenetic research.

• QRICH1, ER Stress, and HMGB1 in HBV Fibrosis

  2026-08-30

  The 2025 Immunobiology study identifies QRICH1 as an important effector linking endoplasmic reticulum stress with HBV-associated HMGB1 transcription, acetylation, translocation, and secretion. Using a chronic rcccDNA mouse model and clinical liver specimens, the work connects this pathway with hepatic fibrosis and provides a framework for separating ER-stress signaling from downstream DAMP release.

• Pretomanid Targets Both Terminal Oxidases in Tuberculosis

  2026-08-29

  The reference study identifies the cytochrome bcc:aa3 and bd terminal oxidases as coordinated respiratory vulnerabilities targeted by pretomanid in Mycobacterium tuberculosis. Its genetic, chemical, and combination evidence supports pairing pretomanid with respiratory inhibitors to enhance killing across replicating and antibiotic-tolerant bacillary states while limiting resistance emergence.

• Camptothecin and the Adaptive Genome Stability Frontier

  2026-08-29

  Camptothecin offers translational researchers a defined topoisomerase I lesion for connecting DNA damage, cell fate, autophagy, and adaptive genome evolution. This article integrates mechanistic validation with the emerging concept that reversible protein self-assembly can tune mutagenesis under drug pressure.

• AI-10-49: Mapping CBFβ-SMMHC in AML

  2026-08-28

  AI-10-49 is a selective CBFβ-SMMHC inhibitor for dissecting RUNX1 dysfunction in inv(16) leukemia. This guide translates target engagement, chromatin recovery, and N-MYC/eIF4G1 biology into a practical assay strategy for acute myeloid leukemia research.

• HyperScribe T7 High Yield Cy3 RNA Labeling Kit Guide

  2026-08-28

  Learn how to tune Cy3-UTP incorporation for bright, reproducible RNA probes in in situ hybridization and Northern blot workflows. This practical guide also shows how fluorescent transcript mapping can complement ROS-responsive mRNA delivery studies without overstating what the labeling chemistry measures.

• Dimetridazole: From Membrane Stress to Assay Design

  2026-08-27

  Dimetridazole, also known as 1,2-Dimethyl-5-nitroimidazole, is more than a conventional antimicrobial assay compound. This guide shows how to connect membrane, quorum-sensing, combination, infection-model, and electrochemical readouts into a stronger research strategy.

• Cytochalasin D in Corneal Nanoparticle Uptake

  2026-08-27

  Cytochalasin D can help distinguish actin-dependent internalization from surface association in corneal nanoparticle assays. This article translates a human corneal epithelial-cell study into a rigorous framework for perturbation design, controls, and interpretation.

• FLAG tag Peptide: Practical Purification Workflows

  2026-08-26

  Use the FLAG tag Peptide (DYKDDDDK) for gentle competitive elution, tag-removal planning, and controlled recombinant protein detection. This workflow also translates single-molecule antibody-screening insights into practical choices for affinity purification and reversible imaging assays.

• Radicicol: Reliable Hsp90 Inhibition in Cell Assays

  2026-08-26

  Learn how Radicicol (SKU A4067) can support interpretable cell viability, differentiation, and apoptosis workflows. This scenario-based guide connects product handling, assay design, potency context, and vendor-selection decisions for biomedical laboratories.

• TRIM66 and the One-Neuron-One-Receptor Rule

  2026-08-25

  The reference study identifies TRIM66 as an epigenetic repressor that helps mature olfactory sensory neurons silence extra olfactory receptor genes after an initially polygenic phase. By linking enhancer repression to receptor singularity, neural activity, and innate olfactory behavior, the work clarifies a central step in sensory-neuron specification and provides a framework for studying cell-to-cell receptor choice.

• HotStart™ 2X Green qPCR Master Mix Guide

  2026-08-25

  HotStart™ 2X Green qPCR Master Mix provides a practical SYBR Green workflow for detecting and quantifying DNA or cDNA while reducing amplification initiated before thermal cycling. It is suitable for real-time PCR gene expression analysis, nucleic acid quantification, and RNA-seq validation, but target-specific performance, cycling conditions, and compatibility with individual instruments must be validated experimentally.

• LMO2–LDB1 Signaling in Acute Myeloid Leukemia

  2026-08-24

  The reference study identifies an LMO2/LDB1 protein complex as a functional driver of acute myeloid leukemia, extending LMO2 biology beyond its established roles in hematopoietic development and T-cell leukemia. Through loss-of-function, interaction mapping, transcriptomics, chromatin profiling, and rescue experiments, the authors connect LDB1 activity with AML-cell proliferation, survival, and apoptosis-related gene regulation.

451 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page